AVITA Medical Statistics
Total Valuation
AVITA Medical has a market cap or net worth of $114.96 million. The enterprise value is $136.42 million.
Important Dates
The last earnings date was Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AVITA Medical has 30.49 million shares outstanding. The number of shares has increased by 4.20% in one year.
| Current Share Class | 30.49M |
| Shares Outstanding | 30.49M |
| Shares Change (YoY) | +4.20% |
| Shares Change (QoQ) | +7.68% |
| Owned by Insiders (%) | 0.97% |
| Owned by Institutions (%) | 22.55% |
| Float | 30.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.40 |
| Forward PS | 1.18 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.88 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.67
| Current Ratio | 0.67 |
| Quick Ratio | 0.52 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.20 |
Financial Efficiency
Return on equity (ROE) is -1,746.27% and return on invested capital (ROIC) is -54.82%.
| Return on Equity (ROE) | -1,746.27% |
| Return on Assets (ROA) | -36.33% |
| Return on Invested Capital (ROIC) | -54.82% |
| Return on Capital Employed (ROCE) | -2,218.40% |
| Revenue Per Employee | $278,465 |
| Profits Per Employee | -$186,750 |
| Employee Count | 260 |
| Asset Turnover | 1.00 |
| Inventory Turnover | 1.75 |
Taxes
In the past 12 months, AVITA Medical has paid $47,000 in taxes.
| Income Tax | 47,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.07% in the last 52 weeks. The beta is 1.65, so AVITA Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.65 |
| 52-Week Price Change | -69.07% |
| 50-Day Moving Average | 4.72 |
| 200-Day Moving Average | 6.65 |
| Relative Strength Index (RSI) | 40.02 |
| Average Volume (20 Days) | 263,143 |
Short Selling Information
| Short Interest | 3.16M |
| Short Previous Month | 3.31M |
| Short % of Shares Out | 11.80% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.76 |
Income Statement
In the last 12 months, AVITA Medical had revenue of $72.40 million and -$48.56 million in losses. Loss per share was -$1.81.
| Revenue | 72.40M |
| Gross Profit | 60.63M |
| Operating Income | -42.08M |
| Pretax Income | -48.51M |
| Net Income | -48.56M |
| EBITDA | -40.03M |
| EBIT | -42.08M |
| Loss Per Share | -$1.81 |
Full Income StatementBalance Sheet
The company has $23.31 million in cash and $44.77 million in debt, giving a net cash position of -$21.46 million or -$0.70 per share.
| Cash & Cash Equivalents | 23.31M |
| Total Debt | 44.77M |
| Net Cash | -21.46M |
| Net Cash Per Share | -$0.70 |
| Equity (Book Value) | -6.67M |
| Book Value Per Share | -0.22 |
| Working Capital | -20.46M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$33.84 million and capital expenditures -$3.29 million, giving a free cash flow of -$37.13 million.
| Operating Cash Flow | -33.84M |
| Capital Expenditures | -3.29M |
| Free Cash Flow | -37.13M |
| FCF Per Share | -$1.22 |
Full Cash Flow StatementMargins
Gross margin is 83.74%, with operating and profit margins of -58.12% and -67.06%.
| Gross Margin | 83.74% |
| Operating Margin | -58.12% |
| Pretax Margin | -67.00% |
| Profit Margin | -67.06% |
| EBITDA Margin | -55.29% |
| EBIT Margin | -58.12% |
| FCF Margin | n/a |
Dividends & Yields
AVITA Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.20% |
| Shareholder Yield | -4.20% |
| Earnings Yield | -42.24% |
| FCF Yield | -32.30% |
Analyst Forecast
The average price target for AVITA Medical is $11.80, which is 213.00% higher than the current price. The consensus rating is "Buy".
| Price Target | $11.80 |
| Price Target Difference | 213.00% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 40.18% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 30, 2020. It was a reverse split with a ratio of 1:5.
| Last Split Date | Jun 30, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
AVITA Medical has an Altman Z-Score of -8.24 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.24 |
| Piotroski F-Score | 2 |
